TuHURA BIOSCIENCES, INC./NV Deferred Income Tax Liabilities, Net
TuHURA BIOSCIENCES, INC./NV (HURA) had Deferred Income Tax Liabilities, Net of $197.92 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-14
- 2026-06-30: Deferred Income Tax Liabilities, Net $197.92K.
- 2026-03-31: Deferred Income Tax Liabilities, Net $197.92K.
- 2025-12-31: Deferred Income Tax Liabilities, Net $197.92K.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $197.92K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $197.92K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $197.92K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |